Abiomed Announces Third Quarter Fiscal 2014 Record Revenue Of $46.2 Million, Up 21% Over The Prior Year

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DANVERS, Mass., Jan. 30, 2014 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today reported third quarter fiscal 2014 revenue of $46.2 million, up 21% compared to revenue of $38.3 million in the same period of fiscal 2013, and a third quarter fiscal 2014 GAAP net income of $4.4 million, or $0.11 per diluted share, compared to $2.7 million, or $0.07 per diluted share, in the prior year period.

Help employers find you! Check out all the jobs and post your resume.

Back to news